Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on ACTION HOTELS PLC. We currently have 10 research reports from 4 professional analysts.
|06Jan17 07:00||RNS||Amendment to Warrant Instrument|
|05Jan17 09:02||RNS||Directors' Dealings|
|04Jan17 07:00||RNS||Closely Associated Person Dealing|
|05Dec16 07:00||RNS||Opening of Mercure Sohar, Oman|
|18Nov16 11:50||RNS||Result of EGM|
|07Nov16 07:00||RNS||Sale of Sharq Investment Land|
|01Nov16 07:00||RNS||Notice Convening Extraordinary General Meeting|
Frequency of research reports
Research reports on
ACTION HOTELS PLC
ACTION HOTELS PLC
Small Cap Breakfast
05 Dec 16
Big Sofa Technologies— Schedule 1 from the b2b technology company providing video analytics at an enterprise level. Seeking to complete RTO of unlisted HubCo investments. Raising £6.1m. Target date 19 December. ECSC—Schedule 1 from provider of cyber security services. Raising £5m. Vendor sale £0.8m. Target date 14 Dec. Expected market cap £15m. RM Secured Direct Lending - The secured direct lending fund intends to float on the Main Market on 15 December raising up to £100m Creo Medical Group - UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. £20m to be raised on Admission with anticipated market cap of £61.2m
New hotel in Melbourne
17 Oct 16
Action Hotels has announced a new hotel in a highly desirable location in Melbourne. This would be its fourth Australian hotel and is a market it knows well with two existing sites in the city. The hotel is expected to open in 2018, and would take its room count close to 3,500 with adjusted EBITDA of $50m in sight. We see this as an exciting development and will adjust our forecasts when the commercial terms become more clear closer to the time. In the meantime, the 2016 dividend yield is 7% and the near term NAV is >100p at current FX. We believe this is a highly attractive investment opportunity with a proven operating model executed by a first class management team.
Solid H1 progress, on track for full year
12 Sep 16
Action Hotels has delivered a robust set of H1 results with adjusted EBITDA progressing +18% YOY as significant investment continues to be made driving +30% YOY increase in rooms (now running in excess of 2,000 rooms). We maintain our headline forecasts on the back of these results, albeit these are slightly more H2 weighted (65% vs. 61% at the adjusted EBITDA level) vs. last year. At current $ spot rates the NAV is likely to exceed 100p if we adjust for the deferred tax provision, and is also backed with a dividend yield of 4% implying compelling value at current levels in our view.
A strong year of progress
18 Apr 16
Action Hotels has delivered a strong set of results, which are in line with our forecasts at the headline revenue and adjusted EBITDA level. The NAV has come in slightly ahead of our forecasts, which is encouraging. We are maintaining our forecasts for now, but remain confident in the investment case, which was set out in our initiation note last week. We continue to believe the shares should be worth in excess of 90p over the medium term, which drives significant upside potential from current levels.
Checking into structural growth
12 Apr 16
Action Hotels (Action) is a profitable, fast-growing hotel business with a strong management team and proven track record of meeting targets and delivering its pipeline. The company serves the undersupplied mid-market/economy segment of the hotel market in the Middle East and Australia and has local expertise in identifying and developing appropriate sites. We believe the current valuation is compelling, backed by a conservative 2014A NAV of 83p, which represents a c.38% discount to the current share price, sector leading growth potential and a dividend yield of 5%.
The Crown Joules
15 Feb 17
We believe that own-brand retailers that operate a balanced multi-channel proposition will be well placed to prosper in a competitive apparel market going forward. Joules is one company in particular which we believe will outperform the sector given its loyal and growing customer base, distinctive brand and strong track record of opening profitable space. We initiate coverage on the shares with a buy recommendation and price target of 249p, implying upside of 16.9% over the prevailing market price.
The Slide Rule
12 Jan 17
What is The Slide Rule? The Slide Rule has been designed to dramatically simplify the identification of the best companies in the UK small/mid-cap sector by making a quantitative assessment of the relative potential of each company. At its core, The Slide Rule aims to identify those companies that create genuine shareholder value through strong returns on capital and solid growth, but also present a value opportunity with the potential tailwind of earnings momentum. Companies are assessed within a Quality, Value, Growth and Momentum (QVGM) framework.
N+1 Singer - Carpetright - Recovery has just begun
17 Feb 17
With UK LFLs up 6.8% in Jan against tough comparatives, and Europe LFLs up 5.4% in Q3, the first clear evidence is now visible that the transformation strategy is gaining momentum. Given some uncertainties, market forecasts are yet to reflect this, but upgrades seem likely as further initiatives are rolled out. Despite a recent bounce from its all time low, the valuation is still very low on consensus assumptions, where risk now appears to be shifting to the upside. With scope for re-rating too, our 300p target price has the scope to grow to 500p over 18 months. We re-initiate with a Buy.
Panmure Morning Note 19-01-2017
19 Jan 17
Pets at Home have released a Q3 trading update this morning that will disappoint the market. Group like-for-like revenue growth was just +0.1% through 3Q16 as subdued trading across the Merchandise business weighed on continued strong growth in Veterinary Services. Profit outlook for FY17 remains in line with expectations. Suspect the shares will come under pressure.